ADIL:Adial Pharmaceuticals Inc * Snapshot | Charting | News | Options
*Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
$4.90 NASDAQ 4:05p ET
August 25 '26 		Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire
Last  Change Exchange
Market data is delayed by at least 15 minutes.
Markets Portfolio
    Symbol Lookup
    Latest Story
    Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
     GlobeNewswire
    Full Story →

    Headline News
    Adial Pharmaceuticals Reports 2026 Second Quarter Financial Results and Provides Business Update
    7:00a ET August 17 '26 GlobeNewswire
    Adial Pharmaceuticals Expands Executive Leadership Team and Closes PIPE Financing
    8:00a ET June 16 '26 GlobeNewswire
    More News →
    Day  18.27%Week  31.18%Month  11.6%More Charting →
    September 11 '26. Markets Closed.
    Last $4.90
    Day change   18.27%$1.10
    Open $6.06
    Gap at open $0.06
    Previous close $6.00
    Trading volume 108,475
    10 Day avg vol. 57,692
    Shares out. 2.6Mil
    Market cap. $12.9Mil
    Trading activity Above Avg.
    Previous data from yesterday, September 10 '26.

    Historical Price Performance
    3 month   64.43% 
    6 month   165% 
    1 year   44.00% 
    2 year   82.02% 

    Earnings
    Previous 12m -$16.57
    Next 12m Estimate -$3.93
    P/E ratio --
    Revenue 0Mil

    Market data provided by News provided by


    This site is published in the United States for U.S. residents only. The services offered within this site are available exclusively through our U.S. Financial Advisors. Stifel Nicolaus Financial Advisors may only conduct business with residents of the state in which they are properly registered. The information on this website is not an offer to sell or a solicitation of an offer to buy, any security, nor shall any such security be offered or sold to any person in any jurisdiction in which such offer, solicitation, purchase or sale may not lawfully be made.
    Important Disclosures | Privacy Notice | HIPAA Policy | Use of Information Policy | Business Continuity | Canada Trade Matching Statement

    Stifel, Nicolaus & Co., Inc. Member NYSE, FINRA, and SIPC.
    Stifel Nicolaus Canada Inc., is a member of CIPF/FCPE and IIROC
    Copyright © 2026 All rights reserved.